Time to benefit of colchicine in patients with cardiovascular disease: A pooled analysis of randomized controlled trials

By sjmartinez • May 10, 2024

Sun H, Huang C, Li L, Zhu W, Li J, Sun P, A G, Fonarow GC, Yang Q, Zhou X. Time to benefit of colchicine in patients with cardiovascular disease: A pooled analysis of randomized controlled trials. Heliyon. 2024 Apr 29;10(9):e30408. doi: 10.1016/j.heliyon.2024.e30408. PMID: 38726146; PMCID: PMC11079085.

Tags: Cardiology/Epi, Colchicine, Major adverse cardiovascular event, meta-analysis, Publications, Time to benefit

Characteristics and Outcomes of Over One Million Veterans with Heart Failure Phenotyped Using Artificial Intelligence Approaches: The National DCVA-HF Registry

Zhang S, Raman VK, Shao Y, Patel S, Cheng Y, Workman TE, Sheriff HM, Fonarow GC, Lam PH, Heidenreich PA, Morgan CJ, Moore HJ, Vargas[...]

Cardiology Provider Knowledge and Attitudes Toward Cardiac Gene Therapy: A Multi-Institutional National Survey

Silver E, Punt M, Wang J, Brann A, Khedraki R, Kumar S, Duran A, Greenberg B, Hong KN, Bui QM. Cardiology Provider Knowledge and Attitudes[...]

Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis

Karpouzas GA, Cosedis Enevoldsen F, Rezaeian P, Masic D, Budoff MJ, Hauge EM, Ormseth SR. Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and[...]